Across K and KP models, GATA6 was predominantly expressed in epithelial hyperplasia, with its levels increasing as adenomas progress (Grades 1–3) and heterogeneously decreasing in late stage adenocarcinomas (Grade 4) (Fig. 1a). This evidence concerns the gene GATA6 and adenoma.